Consolidated Statements of Operations - USD ($)	12 Months Ended
Dec. 31, 2019	Dec. 31, 2018
Condensed Consolidated Statements of Operations
Sales	$ 0	$ 530,000
Cost of goods sold	1,000	427,000
Gross profit (loss)	(1,000)	103,000
Operating expenses:
Research and development, net of grants	3,056,000	4,052,000
General and administrative	5,526,000	5,622,000
Total operating expenses	8,582,000	9,674,000
Loss from operations	(8,583,000)	(9,571,000)
Other income:
Interest income	101,000	71,000
Net loss	(8,482,000)	(9,500,000)
Net loss attributed to noncontrolling interest	3,000
Net loss attributed to common stockholders	$ (8,479,000)	$ (9,500,000)
Net loss per share - basic and fully diluted	$ (0.32)	$ (0.42)
Weighted average number of shares outstanding - basic and fully diluted	26,701,042	22,856,210

The aggregate cost of goods produced and sold and services rendered during the reporting period.

Name:	us-gaap_CostOfRevenue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256